ORF31-06 - Durable Benefits of Targeted Medical Therapy in Primary Aldosteronism: Insights from an International Multicentre Cohort Study

Oral Abstract Presenter(s)

• JY

  Jun Yang, MBBS, FRACP, PhD (she/her/hers)

  Head of Endocrine Hypertension Group
  Hudson Institute of Medical Research
  Clayton, Victoria, Australia

Senior Author/Primary Investigator(s)

• JY

  Jun Yang, MBBS, FRACP, PhD (she/her/hers)

  Head of Endocrine Hypertension Group
  Hudson Institute of Medical Research
  Clayton, Victoria, Australia

Co-Author(s)

• JG

  Jessica Goi, n/a

  University of Torino
  Torino, Piemonte, Italy
• JB

  Jacopo Burrello, JB

  University of Torino
  Torino, Italy
• PI

  PAMO Investigators, N/A

  Hudson Institute Of Medical Research
  Clayton, Victoria, Australia